William Thomsen

2.9k total citations · 1 hit paper
32 papers, 2.2k citations indexed

About

William Thomsen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, William Thomsen has authored 32 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in William Thomsen's work include Receptor Mechanisms and Signaling (14 papers), Ion channel regulation and function (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). William Thomsen is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Ion channel regulation and function (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). William Thomsen collaborates with scholars based in United States, Japan and France. William Thomsen's co-authors include M. Iqbal Choudhary, Atta‐ur Rahman, William A. Catterall, David J. Unett, John Frazer, Andrew J. Grottick, Richard R. Neubig, Brian M. Smith, Michael Morgan and Dominic P. Behan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and The FASEB Journal.

In The Last Decade

William Thomsen

32 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioassay Techniques for Drug Development

2001 723 citations William Thomsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Thomsen United States	18	951	605	518	309	301	32	2.2k
Susan P. Rohrer United States	27	902 0.9×	606 1.0×	348 0.7×	182 0.6×	131 0.4×	60	2.7k
Ram Raghubir India	25	1.3k 1.4×	602 1.0×	791 1.5×	290 0.9×	112 0.4×	71	3.3k
Philip A. Hipskind United States	23	913 1.0×	694 1.1×	617 1.2×	86 0.3×	85 0.3×	41	2.2k
Chandrani Mukherjee United States	22	1.9k 2.0×	487 0.8×	247 0.5×	192 0.6×	220 0.7×	50	3.0k
Raymond S.L. Chang United States	31	2.7k 2.9×	1.6k 2.7×	1.6k 3.1×	374 1.2×	277 0.9×	114	4.7k
Micah J. Niphakis United States	30	1.3k 1.3×	944 1.6×	490 0.9×	1.1k 3.4×	207 0.7×	57	3.1k
Stefanie A. Kane United States	33	1.1k 1.2×	357 0.6×	1.1k 2.2×	126 0.4×	158 0.5×	63	3.1k
Janusz J. Kulagowski United Kingdom	29	1.2k 1.2×	806 1.3×	1.1k 2.1×	160 0.5×	98 0.3×	55	2.3k
H. Timmerman Netherlands	26	1.5k 1.6×	614 1.0×	477 0.9×	286 0.9×	167 0.6×	91	3.1k
Wilma Quaglia Italy	26	1.2k 1.2×	580 1.0×	736 1.4×	150 0.5×	152 0.5×	122	1.9k

Countries citing papers authored by William Thomsen

Since Specialization

Citations

This map shows the geographic impact of William Thomsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Thomsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Thomsen more than expected).

Fields of papers citing papers by William Thomsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Thomsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Thomsen. The network helps show where William Thomsen may publish in the future.

Co-authorship network of co-authors of William Thomsen

This figure shows the co-authorship network connecting the top 25 collaborators of William Thomsen. A scholar is included among the top collaborators of William Thomsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Thomsen. William Thomsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomsen, William, et al.. (2022). Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists. The Journal of Pediatrics. 255. 65–71.e6. 2 indexed citations

Nayak, Surendra Kumar, et al.. (2013). Parathyroid Hormone (PTH) and PTH-Related Peptide Domains Contributing to Activation of Different PTH Receptor–Mediated Signaling Pathways. Journal of Pharmacology and Experimental Therapeutics. 345(3). 404–418. 50 indexed citations

Song, Bowen, et al.. (2013). Investigating hydrophobic ligand–receptor interactions in parathyroid hormone receptor using peptide probes. Journal of Peptide Science. 19(6). 337–344. 2 indexed citations

Semple, Graeme, Thuy-Anh Tran, Sangdon Han, et al.. (2009). Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: In vitro profiling and in vivo evaluation. Bioorganic & Medicinal Chemistry Letters. 19(21). 6166–6171. 3 indexed citations

Al‐Shamma, Hussien, Christen M. Anderson, Emil Chuang, et al.. (2009). Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia. Journal of Pharmacology and Experimental Therapeutics. 332(1). 281–290. 30 indexed citations

Ramirez, Juan Ignacio, Yunqing Shi, William Thomsen, et al.. (2009). APD791, 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a Novel 5-Hydroxytryptamine 2A Receptor Antagonist: Pharmacological Profile, Pharmacokinetics, Platelet Activity and Vascular Biology. Journal of Pharmacology and Experimental Therapeutics. 331(1). 96–103. 17 indexed citations

Thomsen, William, Andrew J. Grottick, Stephen Espitia, et al.. (2008). Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization. Journal of Pharmacology and Experimental Therapeutics. 325(2). 577–587. 320 indexed citations

Santora, Vincent J., Jonathan A. Covel, Michael I. Weinhouse, et al.. (2008). Novel H3 receptor antagonists with improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters. 18(14). 4133–4136. 4 indexed citations

Ramirez, Juan Ignacio, Yunqing Shi, William Thomsen, et al.. (2007). Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist. European Journal of Pharmacology. 586(1-3). 234–243. 19 indexed citations

10.

Smith, Brian M., William Thomsen, & Andrew J. Grottick. (2006). The potential use of selective 5-HT_2Cagonists in treating obesity. Expert Opinion on Investigational Drugs. 15(3). 257–266. 51 indexed citations

11.

Smith, Brian M., Jeffrey M. Smith, James H. Tsai, et al.. (2005). Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 15(5). 1467–1470. 70 indexed citations

12.

Chaki, Shigeyuki, Takeo Funakoshi, Toshiharu Shimazaki, et al.. (2005). Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists. Journal of Pharmacology and Experimental Therapeutics. 313(2). 831–839. 108 indexed citations

13.

Thomsen, William, John Frazer, & David J. Unett. (2005). Functional assays for screening GPCR targets. Current Opinion in Biotechnology. 16(6). 655–665. 178 indexed citations

14.

Thomsen, William, et al.. (1997). Molecular Approaches to Receptors as Targets for Drug Discovery. Journal of Receptors and Signal Transduction. 17(5). 671–776. 21 indexed citations

15.

Thomsen, William, Marie‐France Martin‐Eauclaire, Hervé Rochat, & William A. Catterall. (1995). Reconstitution of High‐Affinity Binding of a β‐Scorpion Toxin to Neurotoxin Receptor Site 4 on Purified Sodium Channels. Journal of Neurochemistry. 65(3). 1358–1364. 16 indexed citations

16.

Thomsen, William, Sheryl J. Hays, James L. Hicks, Roy D. Schwarz, & William A. Catterall. (1993). Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels.. Molecular Pharmacology. 43(6). 955–964. 18 indexed citations

17.

Catterall, William A., Todd Scheuer, William Thomsen, & Sandra Rossie. (1991). Structure and Modulation of Voltage‐Gated Ion Channels. Annals of the New York Academy of Sciences. 625(1). 174–180. 8 indexed citations

18.

Trainer, Vera L., William Thomsen, William A. Catterall, & Daniel G. Baden. (1991). Photoaffinity Labeling of the Brevetoxin Receptor on Sodium Channels in Rat Brain Synaptosomes. Molecular Pharmacology. 40(6). 988–994. 49 indexed citations

19.

Thomsen, William & Richard R. Neubig. (1989). Rapid kinetics of .alpha.2-adrenergic inhibition of adenylate cyclase. Evidence for a distal rate-limiting step. Biochemistry. 28(22). 8778–8786. 23 indexed citations

20.

Thomsen, William, John A. Jacquez, & Richard R. Neubig. (1988). Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.. Molecular Pharmacology. 34(6). 880–887. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact